Today's top medical abstracts
Internal Med
Become a Member Today!
Email
Password
Remember me
Forgot your Password?

Invite Code?

Home
General Internal Med
Messages
Conferences
Jobs
Newsletters
My Library
Topics in
Internal Med
        Academic Med/Education
        Adolescent Medicine
        Allergy/Immunology
        Atherosclerosis/Lipids
        Basic Science/Genetics
        Cardiology
        Clinical Pharmacology
        Complementary Medicine
        Critical Care/
    Hospitalist
        Dermatology
        Economics of Medicine
        Endocrinology
        Epidemiology
        Gastroenterology
        Geriatrics
        Hematology/Oncology
        Infectious Disease
        Nephrology/Urology
        Neurology
        Orthopedic/Physical Med
        Popular Press
        Preventive Medicine
        Primary Care
        Psychiatry
        Pulmonology
        Radiology/Diagnostics
        Rheumatology
        Sports Medicine
        Vascular Medicine
        Women`s Health
 
Help
Resource Center
RSS News Feeds
Send Newsletter
to a Friend
 
Sponsor
Cancer Science: #14. Does Size Matter? "Stumpy" Telomeres Allow Cancer Cells to Evade Senescence
Sara Hartley, MDLinx Oncology
  See all
Article Summary

Click the title below to leave the MDLinx Network and go to the Journal's Website
Management of depression for people with cancer
The Lancet, 07/11/08
Print     Email This Article     Save in My Library   Free Abstract
Strong V et al. - In a study to assess the efficacy and cost of a nurse-delivered complex intervention that was designed to treat major depressive disorder in pts who have cancer, it was found that the intervention-Depression Care for People with Cancer-offers a model for the management of major depressive disorder in pts with cancer and other medical disorders who are attending specialist medical services that is feasible, acceptable, and potentially cost effective

Methods
  • 200 outpatients who had cancer with a prognosis of greater than 6 months and major depressive disorder were eligible and agreed to take part
  • Mean age was 56.6 years, and 71% were women
  • 99 participants were randomly assigned to usual care, and 101 to usual care plus the intervention, with minimisation for sex, age, diagnosis, and extent of disease
  • The intervention was delivered by a cancer nurse at the centre over an average of 7 sessions
  • The primary outcome was the difference in mean score on the self-reported Symptom Checklist-20 depression scale (range 0 to 4) at 3 months after randomisation

Results
  • Primary outcome data were missing for 4 pts
  • For 196 pts for whom data was available at 3 months, the adjusted difference in mean Symptom Checklist-20 depression score, between those who received the intervention and those who did not, was 0.34
  • This treatment effect was sustained at 6 and 12 months
  • The intervention also improved anxiety and fatigue but not pain or physical functioning
  • It cost an additional US$10,556 per quality-adjusted life-year gained

Sponsor
Read a Different Specialty
Allergy/Immunology
Anesthesiology
Cardiology
Dermatology
Drugs
Emergency Medicine
Endocrinology
ENT
Family Medicine
Gastroenterology
Hematology-Oncology
Infectious Disease
Internal Medicine
Nephrology
Neurology
OB/Gyn
Ophthalmology
Orthopedics
Pediatrics
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology
Profession Index
Dentist
Hospital Administrator
Nurse
    Medical Students
Nurse Practitioner
Pharma/Drug Marketer
    Pharmacist
Physician
Physician Assistants
Article Search
Keyword:
Search:
Published within:
Sort By:
Date Relevance
    
Sponsor
About MDLinx  |  Contact  |  Advertise with MDLinx  |  Site Map  |  Privacy Policy  |  Terms of Use  |  Sign Up For Newsletters  |  Recommend this Site

English |  Español |  Français |  Deutsch |  中文 |  Руccкий |  Norsk |  Nederlands |  Português |  Italiano

©1999-2008 MDLinx, Inc.